Search Results - "Guidos, Robert"

Combating Antimicrobial Resistance: Policy Recommendations to Save Lives by Spellberg, Brad, Blaser, Martin, Guidos, Robert J, Boucher, Helen W, Bradley, John S, Eisenstein, Barry I, Gerding, Dale, Lynfield, Ruth, Reller, L Barth, Rex, John, Schwartz, David, Septimus, Edward, Tenover, Fred C, Gilbert, David N

Get full text

10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America by Boucher, Helen W., Talbot, George H., Benjamin, Daniel K., Bradley, John, Guidos, Robert J., Jones, Ronald N., Murray, Barbara E., Bonomo, Robert A., Gilbert, David

“…Infections caused by antibiotic-resistant bacteria, especially the "ESKAPE" pathogens, continue to increase in frequency and cause significant morbidity and…”
Get full text

10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America by Boucher, Helen W, Talbot, George H, Benjamin, Jr, Daniel K, Bradley, John, Guidos, Robert J, Jones, Ronald N, Murray, Barbara E, Bonomo, Robert A, Gilbert, David

“…Infections caused by antibiotic-resistant bacteria, especially the "ESKAPE" pathogens, continue to increase in frequency and cause significant morbidity and…”
Get full text

White Paper: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens

“…There is a critical need for new pathways to develop antibacterial agents to treat life-threatening infections caused by highly resistant bacteria…”
Get full text

Reply to Tillotson, Outterson et al, and Burgess et al by Gilbert, David N., Guidos, Robert J., Boucher, Helen W., Talbot, George H., Spellberg, Brad, Edwards, John E., Michael Scheld, W., Bradley, John S., Bartlett, John G.

Get full text

The 10 X '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020

“…The time has come for a global commitment to develop new antibacterial drugs. Current data document the impending disaster due to the confluence of decreasing…”
Get full text

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America by Spellberg, Brad, Guidos, Robert, Gilbert, David, Bradley, John, Boucher, Helen W., Scheld, W. Michael, Bartlett, John G., Edwards, John

“…The ongoing explosion of antibiotic-resistant infections continues to plague global and US health care. Meanwhile, an equally alarming decline has occurred in…”
Get full text

Discovery research: the scientific challenge of finding new antibiotics by Livermore, David M.

“…The dwindling supply of new antibiotics largely reflects regulatory and commercial challenges, but also a failure of discovery. In the 1990s the pharmaceutical…”
Get full text

The urgent need for new antibacterial agents by Wise, Richard

Get full text

Effective antibacterials: at what cost? The economics of antibacterial resistance and its control by White, Anthony R.

“…The original and successful business model of return on investment being sufficiently attractive to the pharmaceutical industry to encourage development of new…”
Get full text

Anti-infective research and development—problems, challenges, and solutions by Bradley, John S, Guidos, Robert, Baragona, Steve, Bartlett, John G, Rubinstein, Ethan, Zhanel, George G, Tino, Michael D, Pompliano, David L, Tally, Frank, Tipirneni, Praveen, Tillotson, Glenn S, Powers, John H

Get full text

Regulatory opportunities to encourage technology solutions to antibacterial drug resistance by Finch, Roger

“…Regulatory agencies play a critical role in the licensing of new antimicrobial agents. To address the pivotal role played by regulatory agencies, particularly…”
Get full text